☰

Mi-Seon Seong, Ph.D. - Publications

Affiliations: 
2006 Texas A & M University, College Station, TX, United States 
Area:
Botany Biology, Molecular Biology, Plant Physiology
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Lee I, Lim I, Byun BH, Kim BI, Choi CW, Woo SK, Kim KI, Lee KC, Kang JH, Seong MK, Kim HA, Noh WC, Lim SM. A preliminary clinical trial to evaluate Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer. Ejnmmi Research. 11: 8. PMID 33475899 DOI: 10.1186/s13550-021-00746-1  0.555
2020 Choi JH, Kim HA, Kim W, Lim I, Lee I, Byun BH, Noh WC, Seong MK, Lee SS, Kim BI, Choi CW, Lim SM, Woo SK. Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning. Scientific Reports. 10: 21149. PMID 33273490 DOI: 10.1038/s41598-020-77875-5  0.58
2020 Kim J, Kim JY, Lee HB, Lee YJ, Seong MK, Paik N, Park WC, Park S, Jung SP, Bae SY. Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type. Breast Cancer Research and Treatment. PMID 32794061 DOI: 10.1007/s10549-020-05861-6  0.323
2020 Choi J, Park CS, Seong MK, Seol H, Kim JS, Park IC, Noh WC, Kim HA. Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status. Journal of Breast Cancer. 23: 10-19. PMID 32140266 DOI: 10.4048/jbc.2020.23.e5  0.316
2019 Kim N, Choi J, Ko E, Kim SH, Jun J, Kim H, Noh WC, Seong M. Predictive Value of the Standardized Uptake Value of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Assessing Axillary Lymph Node Metastasis in Different Subtypes of Breast Cancer Journal of Breast Disease. 7: 65-72. DOI: 10.14449/jbd.2019.7.2.65  0.438
2019 Lee I, Woo S, Chul Noh W, Ho Choi J, Hyun Byun B, Il Kim B, Choi CW, Moo Lim S, Lim I, Mo Kang C, Il Kim K, Chul Lee K, Jin Lee Y, Hyun Kang J, Seong M, et al. Dosimetry Prediction of 225Ac-NOTA-Trastuzumab Based on 64Cu-NOTA-Trastuzumab in Breast Cancer: Preliminary Microdose Clinical Trial Journal of Medical Imaging and Radiation Sciences. 50: S72. DOI: 10.1016/j.jmir.2019.11.024  0.374
2019 Lee I, Woo S, Chul Noh W, Ho Choi J, Hyun Byun B, Il Kim B, Choi CW, Moo Lim S, Lim I, Mo Kang C, Il Kim K, Chul Lee K, Jin Lee Y, Hyun Kang J, Seong M, et al. Dosimetry Prediction of 225Ac-NOTA-Trastuzumab Based on 64Cu-NOTA-Trastuzumab in Breast Cancer: Preliminary Microdose Clinical Trial Journal of Medical Imaging and Radiation Sciences. 50: S6. DOI: 10.1016/j.jmir.2019.03.019  0.374
2018 Lee JS, Oh S, Park SK, Lee MH, Lee JW, Kim SW, Son BH, Noh DY, Lee JE, Park HL, Kim MJ, Cho SI, Lee YK, Park SS, Seong MW. Reclassification of and variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort. Journal of Medical Genetics. PMID 30415210 DOI: 10.1136/jmedgenet-2018-105565  0.342
2018 Park S, Moon BI, Oh SJ, Lee HB, Seong MK, Lee S, Byun KD, Jung SP, Bae SY. Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society. Breast Cancer Research and Treatment. PMID 30390214 DOI: 10.1007/s10549-018-5032-3  0.377
2018 Choi JH, Lim I, Noh WC, Kim HA, Seong MK, Jang S, Seol H, Moon H, Byun BH, Kim BI, Choi CW, Lim SM. Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer. Annals of Nuclear Medicine. PMID 29797002 DOI: 10.1007/s12149-018-1259-7  0.583
2018 Kim YG, Yoon YN, Choi HS, Kim JH, Seol H, Lee JK, Seong MK, Park IC, Kim KI, Kim HA, Kim JS, Noh WC. Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer. Oncotarget. 9: 5811-5822. PMID 29464036 DOI: 10.18632/oncotarget.23528  0.388
2017 Lee S, Jeong H, Seong M, Kim JG. Change of tumor vascular reactivity during tumor growth and postchemotherapy observed by near-infrared spectroscopy. Journal of Biomedical Optics. 22: 121603. PMID 28698890 DOI: 10.1117/1.Jbo.22.12.121603  0.329
2017 Kim HA, Kim JH, Choi HS, Kim YG, Lee SJ, Han KH, Seong MK, Seol HS, Noh WC. Core Needle Biopsy Specimens Are More Appropriate than Surgical Specimens for Evaluating the Expression of Phosphoproteins as Biological Markers in Invasive Breast Cancer. Anticancer Research. 37: 1409-1412. PMID 28314311 DOI: 10.21873/ANTICANRES.11463  0.315
2017 Ko E, Seong M, Choi HS, Park CS, Choi JH, Lee J, Seol H, Kim H, Noh WC. Phosphorylated S6 Kinase-1 as Predictive Marker of Lapatinib Efficacy in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients Journal of Breast Disease. 5: 57-63. DOI: 10.14449/jbd.2017.5.2.57  0.311
2017 Noh YH, Kim YG, Kim JH, Choi HS, Lee SJ, Kim J, Park IC, Seong MK, Kim H, Noh WC. Factors Associated with Metastatic Breast Cancer in Patients Who Show Long-Term Stable Disease Status Journal of Breast Disease. 5: 1-7. DOI: 10.14449/jbd.2017.5.1.1  0.324
2017 Kim H, Woo J, Choi HS, Lee SJ, Choi J, Park CS, Seong M, Noh WC. The Examination of Ovarian Reserve in Premenopausal Patients with Hormone Receptor Positive Breast Cancer The Ewha Medical Journal. 40: 104. DOI: 10.12771/emj.2017.40.3.104  0.339
2017 Choi J, Choi HS, Lee SJ, Park CS, Kim H, Seong M, Gwak G, Noh WC. Does Eribulin Have an Effect on Anti-Tumor Activities of the Subsequent Regimen Used in Metastatic Breast Cancer The Breast. 36: S60. DOI: 10.1016/s0960-9776(17)30725-7  0.354
2016 Seong M, Ko EY, Han BK, Cho SY, Cho EY, Lee SK, Lee JE. Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review. Journal of Breast Cancer. 19: 330-333. PMID 27721884 DOI: 10.4048/jbc.2016.19.3.330  0.336
2016 Kim HA, Seong MK, Kim JH, Kim YG, Choi HS, Kim JS, Park IC, Jin HO, Lee JK, Noh WC. Prognostic Value of Anti-Müllerian Hormone and Inhibin B in Patients with Premenopausal Hormone Receptor-positive Breast Cancer. Anticancer Research. 36: 1051-7. PMID 26976997  0.318
2016 Kim JS, Kim HA, Seong MK, Seol H, Oh JS, Kim EK, Chang JW, Hwang SG, Noh WC. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers. Oncotarget. PMID 26755645 DOI: 10.18632/oncotarget.6855  0.367
2015 Kim HA, Seong MK, Kim EK, Kang E, Park S, Hur MH, Song BJ, Noh WC. Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer. Journal of Breast Cancer. 18: 271-8. PMID 26472978 DOI: 10.4048/jbc.2015.18.3.271  0.314
2015 Seong MK, Lee JY, Byeon J, Sohn YJ, Seol H, Lee JK, Kim EK, Kim HA, Noh WC. Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer. Breast Cancer Research and Treatment. 150: 141-8. PMID 25682076 DOI: 10.1007/s10549-015-3305-7  0.356
2014 Ha JH, Seong MK, Kim EK, Lee JK, Seol H, Lee JY, Byeon J, Sohn YJ, Koh JS, Park IC, Noh WC, Kim HA. Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients. Journal of Breast Cancer. 17: 33-9. PMID 24744795 DOI: 10.4048/jbc.2014.17.1.33  0.369
Show low-probability matches.